US Stock Market Move | Launch of generic weight loss drug Wegovy imitation Hims & Hers Health (HIMS.US) soared nearly 14% in premarket trading.

On Thursday, Hims & Hers Health (HIMS.US) surged nearly 14% in pre-market trading, reaching $27.77 per share. According to reports, the company has started offering a generic version of the newly launched Wegovy pill for a discounted price of $49 per month, which is around $100 cheaper than the branded drug. Hims stated that this therapy can be customized for patients who prefer to avoid side effects or prefer pills over injection options. "We are excited to have found a way to continue launching branded treatment options across specialties through our platform. Having more choices on the platform is the best thing for customers," said Hims CEO Andrew Dudum in a statement.